Anti-ADAM9 Antibody (Imgc936)
Catalog No.
F1664
Anti-ADAM9 Antibody (Imgc936)
Featured Products
Anti-ADAM9 (Imgc936) is a humanized antibody targeting ADAM metallopeptidase domain 9 (ADAM9). It is a drug candidate for the treatment of multiple cancers, including non-small cell lung cancer, pancreatic cancer, gastric cancer, breast cancer, ovarian cancer, and colorectal cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
147.62 kDa
Dry ice
2642078-62-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
AEX6003
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q13443
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The endocytosis ratio Imgc936 by Human ADAM9 HT29 increased with the increase of antibody concentration, and the Internalization Rate (%) reached 50% at antibody concentration of 1 nM.
ADAM9
Please avoid freeze-thaw cycles.